Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,017 public trials 1,024 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Active, Not Recruiting

177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer

NCT04689828

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
  • Tulane Uni Health Sciences Center New Orleans, Louisiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 72 locations
View Trial Details
Active, Not Recruiting

A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

NCT03431350

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Urological Associates of Southern Arizona, P.C. Tucson, Arizona, United States
  • The Urology Center of Colorado Denver, Colorado, United States
  • Mayo Clinic - Division Of Hematology/oncology Jacksonville, Florida, United States
  • First Urology, PSC Jeffersonville, Indiana, United States
View all 50 locations
View Trial Details
Active, Not Recruiting

A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice

NCT07344779

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Many Locations Multiple Locations, Belgium
  • Many Locations Multiple Locations, Finland
  • Many Locations Multiple Locations, France
  • Many Locations Multiple Locations, Germany
View all 16 locations
View Trial Details
Active, Not Recruiting

An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT02257736

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Phoenix, Arizona, United States
  • La Mesa, California, United States
  • Los Angeles, California, United States
  • Modesto, California, United States
View all 173 locations
View Trial Details
Active, Not Recruiting

A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC

NCT02489318

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Homewood, Alabama, United States
  • Tucson, Arizona, United States
  • San Bernardino, California, United States
  • San Diego, California, United States
View all 220 locations
View Trial Details

Related conditions